Aging and cancer: Plasma antioxidants and lipid peroxidation in young and aged breast cancer patients

  • Mariette Gerber
  • Claire Ségala
Part of the EXS book series (EXS, volume 62)


The relationship between aging and cancer is complex because the intrication takes place at the cell, the organism and the environment levels. On the other hand, carcinogenesis is a multi-step process, and different mechanisms may be involved in each step. For example, oxidants and antioxidants may play a different role depending upon the phase considered. Tumors in older patients are generally described as slow growing. The difference in tumor aggressiveness between young and older patients is especially obvious in breast cancer patients. The age specificity of some breast risk factors suggests that breast cancer which has been diagnosed in an aged woman was induced late in her life. We address the question whether the characteristics of a senescent organism with regards to oxidant-antioxidant status could be causally related to the slow evolution of tumors in old patients.


Breast Cancer Aged Group Invasive Lobular Carcinoma Invasive Adenocarcinoma Aneuploid Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adami, H., Malker, B., Holmberg, L., et al. (1986) The relation between survival and age at diagnosis in breast cancer. N. Engl. J. Med. 315: 559–563.PubMedCrossRefGoogle Scholar
  2. Allen, C., Cox, E. B., Mantón, K. G., and Cohen, H. J. (1986) Breast cancer in the elderly: current patterns of care. J. Am. Geriatr. Soc. 34: 37–42.Google Scholar
  3. Ames, B. N. (1988) Measuring oxidative damage in humans: relation to cancer and ageing. I.A.R.C. Sci. Publ. 89: 407–416.Google Scholar
  4. Baranovsky, A., and Myers, M. (1986) Incidence and survival in patients 65 years of age and older. CA 36: 27–41.CrossRefGoogle Scholar
  5. Burton, G. W., Cheeseman, K. H., Doba, T., et al. (1983) Vitamin E as an anti-oxydants in vitro and in vivo, in: Ciba Foundation symposium 101, Biology of Vitamin E, London, Pitman, pp. 4–14.Google Scholar
  6. Cavallo, F., Gerber, M., Marubini, E., Richardson, S., et al. (1989) Zinc and Copper in breast cancer. A joint study in Northern Italy and Southern France. Cancer 64: 2347–2353.Google Scholar
  7. Cerutti, P. A. (1985) Pro-oxidant state and tumor promotion. Science 227: 375–381.PubMedCrossRefGoogle Scholar
  8. Cerutti, P. A. (1989) Response modification in carcinogenesis. Env. Health Persp. 81: 39–43.CrossRefGoogle Scholar
  9. Charilon, M. E., and Feinstein, A. R. (1982) Rapid growth rate in breast cancer: a confounding variable in adjuvant and chemotherapy trials. Lancet 1343–1345.Google Scholar
  10. Cheeseman, K. H., Coliins, M., Proudfoot, K., et al. (1986) Studies on Hpid peroxidation in normal and tumor tissues. The Novikoff rat liver tumour. Biochem. J. 235: 507–514.Google Scholar
  11. Cheeseman, K. H., Emery, S., Maddix, S. P., et al. (1988) Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour. Biochem. J. 250: 247–252.Google Scholar
  12. Collechi, P., Cafiero, F., Vercchio, C., et al. (1987) Erythrocyte, plasma and serum level of zinc and copper in normal subjects and in patients with rectal cancer. Medical Science Research 15: 1073–1074Google Scholar
  13. Cox, E. B. (1987) Breast cancer in the elderly. Clin. Geriatr. Med. 3: 695–713.PubMedGoogle Scholar
  14. Crawford, J., and Cohen, H. J. (1987) Relationship of cancer and ageing. Clin. Geriatr. Med. 3: 419–432.PubMedGoogle Scholar
  15. Dewis, W., and Pories, W. J. (1972) Inhibition of spectrum of animal tumors by dietary zinc deficiency. J. Natl. Cancer Inst. 48: 375–381.Google Scholar
  16. Dewis, W., Pories, W. J., Richter, M. C., et al. (1970) Inhibition of Walker 256 carcinosarcoma growth by dietary zinc deficiency. Proc. Soc. Exp. Biol. Med. 135: 17–22.Google Scholar
  17. Di IHo, C., Saccheta, P., Del Boccio, G., et al. (1985) Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue. Cancer Lett. 29: 37.CrossRefGoogle Scholar
  18. Dixon, J. M., Page, D. L., Anderson, T. J., et al. (1985) Long-term survivors after breast cancer. Br. J. Surg. 72: 445–448.PubMedCrossRefGoogle Scholar
  19. Dornand, J., and Gerber, M. (1989) Inhibition of murine T cell responses by antioxidants: the targets of Hpoxigenase pathway inhibitors. Immunology 68: 384–391.PubMedGoogle Scholar
  20. Ershler, W. B. (1986) Why tumors grow more slowly in old people. J.N.C.I. 77: 837–839.Google Scholar
  21. Fenton, M. R., and Burke, J. P. (1985) Subcellular zipc distribution in Hvers and tumors of plasmocytoma-bearing mice. Nutr. Res., 5: 1383–1391.CrossRefGoogle Scholar
  22. Fenton, M. R., Burke, J. P., Tursi, F. D., and Arena, F. P. (1980) Effect of a zinc deficient diet on the growth of a IgM secreting plasmocytoma (TEPC-183). JNCL 65: 1271–1282.Google Scholar
  23. Garofalo, J., Ashikari, H., Lesser, M. L., Budrick, S. J., and Bodey, G. P. (1980) Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions. Cancer 46: 2682–2685.PubMedCrossRefGoogle Scholar
  24. Gentiii, C., Sanfilippo, O., and Silvestrini, R. (1981) Cell proliferation and its relationship to clinical features and relapse in breast cancer. Cancer 48: 974–979.CrossRefGoogle Scholar
  25. Gerber, M., Cavallo, F., Marubini, E., et al (1988) Liposoluble vitamins and lipid parameters in breast cancer. A joint study in Northern Italy and Southern France. Int. J. Cancer 42: 489–494.PubMedCrossRefGoogle Scholar
  26. Gerber, M., Richardson, S., Crastes de Paulet, P., et al. (1989) Relationship between vitamin E and poly-unsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer 64: 2347–2353.PubMedCrossRefGoogle Scholar
  27. Gerber, M., Richardson, S., Favier, F., and Crastes de Paulet, A. (1990) Vitamin E and tumor growth, in: Antioxidants in Therapy and Medicine. Ed. I. Emerit et al. p. 129–132.CrossRefGoogle Scholar
  28. Gerber, M., Richardson, S., Salkeld, R., and Chappuis, P. (1991) Anti-oxydants in female breast cancer patients. Cancer Inv. 9: 421–428.CrossRefGoogle Scholar
  29. Goldstein, S. (1990) Replicative senescence: The human fibroblast comes of age. Science 249: 1129–1132.PubMedCrossRefGoogle Scholar
  30. Hayflick, L., and Moorhead, P. S. (1961) Human diploid cell lines. Exp. cell. Res. 25: 585–589.CrossRefGoogle Scholar
  31. Herbsman, H., Feldman, J., Seldera, J., et al. (1981) Survival following breast cancer surgery in the elderly. Cancer 47: 2358–2363.PubMedCrossRefGoogle Scholar
  32. Keiner, M. J. (1990) Abnormal cell growth induced by antioxidant enzyme imbalances. Free Rad. Biol. Med. 9: Suppl 1, 132.Google Scholar
  33. Kinzel, v., Fürstenberger, G., Loehrke, H., et al. (1986). Three-stage tumorigenesis in mouse skin: DNA synthesis as a prerequisite for the conversion stage induced by TPA prior to initiation. Carcinogenesis 7: 779–782.PubMedCrossRefGoogle Scholar
  34. Lanson, M., Bougnoux, P., Besson, P., et al. (1990) n-6 Polyunsaturated fatty acids in human breast carcinoma phophatylethanolamine in early relapse. Brit. J. Cancer 61: 776–778.PubMedCrossRefGoogle Scholar
  35. Lee, F. Y. F., Veyssey, A., Rofstad, E., et al. (1989) Heterogeneity of glutathione content in human ovarian cancer. Cancer Res. 49: 5244–5248.PubMedGoogle Scholar
  36. Masotti, L., Casali, E., and Galeotti, T. (1988) Lipid peroxidation in tumour cells. Free Radical Biol. Med. 4: 377–386.CrossRefGoogle Scholar
  37. Meyer, F., and Verreault, R. (1987) Erythrocyte selenium and breast cancer risk. Amer. J. Epidemiol. 125: 917–919.Google Scholar
  38. Meyer, J. S., and Hixon, B. (1979) Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. Cancer Res. 39: 4042–4047.PubMedGoogle Scholar
  39. Mills, B. L., Broghamer, W. L., Higgins, P. J., and Lindeman, R. D. (1981) A specific dietray zinc requirement for the growth of the Walkner 256/Ml tumor in the rat. Am. J. Clin. Nutr. 34: 1661–1669.PubMedGoogle Scholar
  40. Mills, B. L., Broghamer, W. L., Higgins, P. J., and Lindeman, R. D. (1984) Inhibition of tumor growth by zinc depletion of rats. J. Nutr. 114: 746–756.PubMedGoogle Scholar
  41. Minkel, D. T., Dolhum, P. J., Calhoun, B. L., Saryan, L. A., and Petering, D. H. (1979) Zinc deficiency and growth of Ehrlich ascites tumors. Cancer Res. 39: 2451–2456.PubMedGoogle Scholar
  42. Mor, v. (1988) Malignant disease and the elderly. Research and the ageing population. Wiley, Chichester (Ciba Foundation Symposium 134) pp. 160–176.Google Scholar
  43. Mueller, C. B., Ames, F., and Anderson, G. D. (1978) Breast cancer in 3558 women. Age as a significant determination in the rate of dying and causes of death. Surgery (St Louis) 83: 123–132.Google Scholar
  44. Muller, W., and Iffand, R. (1981) Studies metals in meningiomas measured by atomic absorption spectrometry. Acta neuropathol. 55: 53–58.PubMedCrossRefGoogle Scholar
  45. Nakamura, Y., Colbur, N. H., and Gindhart, T. D. (1985) Role of reactive oxygen in tumor promotion: Implication of superoxide anion in promotion of neoplastic transformation in JB6 cells by TPA. Carcinogenesis 6: 229–235.PubMedCrossRefGoogle Scholar
  46. Newel, G. R., Spitz, M. R., and Silder, J. G. (1989) Cancer and age. Seminars in Oncology 16: 3–9.Google Scholar
  47. Poubelle, P., Chaintreuil, J., and Bensadou, J. (1982) Plasma Hpoperoxides and ageing. Biomedicine 36: 164–166.Google Scholar
  48. Rogulji’c, A., Roth, A., Kolari, C. K., and Marici, C. Z. (1980) Iron, copper and zinc liver tissue levels in patients with malignant lymphoma. Cancer 46: 565–569.CrossRefGoogle Scholar
  49. Rougereau, A., Person, O., and Rougereau, G. (1987) Fat soluble vitamins and cancer localization associated to an abnormal ketone derivative of D3 vitamin: Carcinomedin. Internat. J. Vit. Nutr. Res. 57: 367–373.Google Scholar
  50. Schreck, R., Rieber, P., and Baeuerle, P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO 10: 2247–2248.Google Scholar
  51. Segala, C., Gerber, M., and Richardson, S. (1991) The pattern of risk factors for breast cancer in a Southern France population, Interest for a stratified analysis by age at diagnosis. Brit. J. Cancer 64: 919–925.PubMedCrossRefGoogle Scholar
  52. Simpson, H. W., Pauson, A. W., and Griffiths, K. (1988) Genesis of breast cancer is in the premenopause. The Lancet 9: 74–76.CrossRefGoogle Scholar
  53. Smaaland, R., Svardal, A. M., Lote, K., et al. (1991) Glutathione content in bone marrow and circadian stage relation to DNA synthesis. J. Natl. Cancer Inst. 83: 1092–1098.PubMedCrossRefGoogle Scholar
  54. Stewart, J. A. (1989) Breast cancer and ageing. Seminars in Oncology 16: 41–50.PubMedGoogle Scholar
  55. Strauss, M. J., and Moran, R. E. (1980) The cell cycle kinetics of human breast cancer. Cancer 46: 2634–2639.CrossRefGoogle Scholar
  56. Teeter, S. M., Holmes, F. F., and McFarlane, M. J. (1987) Lung carcinoma in the elderly population. Cancer 60: 1331–1336.PubMedCrossRefGoogle Scholar
  57. Tolonen, M., Halme, M., and Sarna, S. (1985) Vitamin E and selenium supplementation in geriatric patients. A double bhnd perliminary chnical trail. Biol. Trace Element. Res. 7: 161–168.CrossRefGoogle Scholar
  58. Tubiana, M. (1989) Tumor cell prohferation kinetics and tumor growth rate. Acta Oncol. 28: 113–121.PubMedCrossRefGoogle Scholar
  59. Yancik, R., Ries, L. G., and Yates, J. W. (1989) Breast cancer in ageing women. 63: 979–81.Google Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 1992

Authors and Affiliations

  • Mariette Gerber
    • 1
  • Claire Ségala
    • 1
  1. 1.Groupe d’Epidémiologie métaboliqueINSERM-CRLCMontpellier Cedex 5France

Personalised recommendations